CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Saved in:
Published in | Leukemia Vol. 38; no. 7; pp. 1621 - 1625 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group
01.07.2024
Nature Publishing Group UK |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
---|---|
ISSN: | 0887-6924 1476-5551 1476-5551 |
DOI: | 10.1038/s41375-024-02290-y |